LOGIN  |  REGISTER
Recursion
Astria Therapeutics

Streamline Health Solutions Debuts eValuator™ Quality Module

October 08, 2024 | Last Trade: US$2.10 0.11 -4.88

Atlanta, Oct. 08, 2024 (GLOBE NEWSWIRE) --  Streamline Health Solutions, Inc. (NASDAQ: STRM), a leading provider of solutions that enable healthcare providers to improve financial performance, announced that it has debuted a new quality module for eValuator and successfully implemented that module at an existing eValuator client.

Streamline Health is leading an industry movement to improve hospital financial performance through pre-bill technology solutions. eValuator’s AI-enhanced pre-bill code auditing ensures that providers can accurately capture, bill and ultimately be paid for all the care they provide while avoiding denials. The eValuator quality module enables health systems to prospectively assess the risk score of individual claims and their estimated impact on overall quality measurement in real time. By eliminating manual, post-hoc risk scoring practices, the quality module introduces an industry-leading workflow that allows for correction of coding errors signaled by risk scores.

“We developed the quality module based on market research and were fortunate to build it in collaboration with existing eValuator clients to provide maximum value for health systems nationwide.” stated Ben Stilwill, President and Chief Executive Officer, Streamline. “We expect the insights this quality module delivers will improve the quality of care our clients are able to provide while bolstering our ability to ensure health systems are accurately paid for the care they’ve provided.”

About Streamline Health

Streamline Health Solutions, Inc. (Nasdaq: STRM) enables healthcare organizations to proactively address revenue leakage and improve financial performance. We deliver integrated solutions, technology-enabled services and analytics that drive compliant revenue leading to improved financial performance across the enterprise. For more information, visit www.streamlinehealth.net

Stock Quote

Featured Stock

ClearPoint Neuro

ClearPoint Neuro is a global therapy-enabling platform company providing stereotactic navigation and delivery to the brain. Applications of our ClearPoint Neuro Navigation System include electrode lead placement, placement of catheters, and biopsy. The platform has FDA clearance and is...

CLICK TO LEARN MORE

Featured Stock

Compass Therapeutics

Compass Therapeutics is a clinical-stage, oncology-focused biopharmaceutical company developing proprietary antibody-based therapeutics to treat multiple human diseases. The company's scientific focus is on the relationship between angiogenesis, the immune system, and tumor growth...

CLICK TO LEARN MORE

End of content

No more pages to load

Next page

COPYRIGHT ©2023 HEALTH STOCKS HUB